Condensed Consolidated Statements of Shareholders' Equity (Deficit) (Unaudited) - USD ($) shares in Millions, $ in Millions	Total	Ordinary Shares and Additional Paid-in Capital	Accumulated Deficit	Accumulated  Other Comprehensive Loss, Net of Tax	Non- controlling Interests
Beginning Balance (in shares) at Dec. 31, 2021		214.8
Beginning Balance at Dec. 31, 2021	$ 1,158	$ 6,626	$ (1,694)	$ (3,871)	$ 97
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,048		1,023		25
Shares issued - employee stock compensation plans (in shares)		0.9
Shares issued - employee stock compensation plans	(116)	$ (116)
Shares repurchased (in shares)		(2.8)
Shares repurchased	(828)		(828)
Share-based compensation expense	119	$ 119
Dividends to shareholders	(110)		(110)
Net change in fair value of financial instruments	1			1
Net foreign currency translation adjustments	(7)			(6)	(1)
Net postretirement benefit obligation	33			33
Dividends paid to noncontrolling interests on subsidiary common stock	(7)				(7)
Ending Balance (in shares) at Mar. 31, 2022		212.9
Ending Balance at Mar. 31, 2022	$ 1,291	$ 6,629	(1,609)	(3,843)	114
Beginning Balance (in shares) at Dec. 31, 2022	205.4	205.4
Beginning Balance at Dec. 31, 2022	$ (429)	$ 6,866	(2,772)	(4,623)	100
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,079		1,050		29
Shares issued - employee stock compensation plans (in shares)		0.9
Shares issued - employee stock compensation plans	(132)	$ (131)	(1)
Shares repurchased (in shares)		(1.8)
Shares repurchased	(550)		(550)
Share-based compensation expense	127	$ 127
Dividends to shareholders	(115)		(115)
Net change in fair value of financial instruments	3			3
Net foreign currency translation adjustments	54
Net postretirement benefit obligation	22			22
Dividends paid to noncontrolling interests on subsidiary common stock	$ (1)				(1)
Ending Balance (in shares) at Mar. 31, 2023	204.5	204.5
Ending Balance at Mar. 31, 2023	$ 58	$ 6,862	$ (2,388)	$ (4,544)	$ 128